Stockscreener 앱 받기
372.42
0.56%
-2.10
시장 영업 전:
373.99
1.57
+0.42%
Elevance Health Inc 주식(ELV)의 최신 뉴스
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness - simplywall.st
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - FinancialContent
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - StreetInsider
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesELV - PR Newswire
Is Weakness In Elevance Health, Inc. (NYSE:ELV) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for - GlobeNewswire
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - WV News
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - MarketScreener
INVESTOR ALERT: Berger Montague Advises Elevance Health (ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - TradingView
ELV Lead Plaintiff Deadline ApproachingRobbins LLP Reminds Investors to Get Information About Leading the Class Action Against Elevance Health, Inc. - The Malaysian Reserve
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating - MSN
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are - GlobeNewswire
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 11 Deadline (NYSE:ELV) - TradingView
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
June 13Parkview Health and Anthem still at odds ahead of contract deadline - Fort Wayne Business Weekly
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
8 Best Inexpensive Stocks to Buy Right Now - Insider Monkey
ELV CLASS ACTION: Invest in Elevance Health, Inc.? Contact - GlobeNewswire
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ELEVANCE HEALTH (ELV) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By July 11, 2025 - TradingView
$1000 Invested In Elevance Health 15 Years Ago Would Be Worth This Much TodayElevance Health (NYSE:ELV) - Benzinga
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Reasonably Well - Yahoo Finance
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit - GuruFocus
UnitedHealth's Medical Membership Rises: Can It Maintain the Momentum? - The Globe and Mail
Elevance Health (ELV): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Elevance Health (NYSE:ELV) PT Set at $500.00 by Truist Financial - Defense World
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - marketscreener.com
ELV LEGAL NOTICE: Lose Money when Elevance Health, Inc. Stock Plummeted 11%? Contact BFA Law by the July 11 Court Deadline (NYSE:ELV) - TradingView
Elevance Health (ELV) Reported Strong Q1 Results - Insider Monkey
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
Elevance Health (NYSE:ELV) Price Target Cut to $500.00 by Analysts at Truist Financial - Defense World
Truist Adjusts Price Target for Elevance Health (ELV) Amid Positive Outlook | ELV Stock News - GuruFocus
Elevance Health (ELV) Stock Rating Maintained by Truist Securiti - GuruFocus
Elevance Health (ELV) Stock Rating Maintained by Truist Securities | ELV Stock News - GuruFocus
Elevance Health Stock Declines, Highlighting a Volatile Month - Daily Chhattisgarh News
Johnson Fistel, PLLP Alerts Shareholders of Fortrea - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance - StreetInsider
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Sec - GuruFocus
0.83%
2.07%
자본화:
|
볼륨(24시간):